Clinical Trial Update: Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer [Phase 1]

View source ↗

Summary

This update reports results from a Phase 1 trial evaluating sulindac for preventing breast cancer in women at high risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sulindac (sulindac)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED